Articles

Impaired mitochondrial activity explains platelet dysfunction in thrombocytopenic cancer patients undergoing chemotherapy

Department of Biochemistry, Cardiovascular Research Institute Maastricht, Maastricht University Medical Centre, the Netherlands
Department of Hematology, Maastricht University Medical Centre, the Netherlands
Central Diagnostic Laboratory, Maastricht University Medical Centre, the Netherlands
Department of Biochemistry, Cardiovascular Research Institute Maastricht, Maastricht University Medical Centre, the Netherlands;Department of Protein Dynamics, Leibniz Institute for Analytical Sciences - ISAS-e.V., Dortmund, Germany
Central Diagnostic Laboratory, Maastricht University Medical Centre, the Netherlands
Central Diagnostic Laboratory, Maastricht University Medical Centre, the Netherlands;Laboratory for Clinical Thrombosis and Hemostasis, Department of Internal Medicine, Cardiovascular Research Institute Maastricht, Maastricht University Medical Center, the Netherlands
Department of Cell Biology and Department of Clinical Chemistry and Haematology, University Medical Center Utrecht, the Netherlands
Department of Biochemistry, Cardiovascular Research Institute Maastricht, Maastricht University Medical Centre, the Netherlands;Laboratory for Clinical Thrombosis and Hemostasis, Department of Internal Medicine, Cardiovascular Research Institute Maastricht, Maastricht University Medical Center, the Netherlands
Department of Human Health and Nutritional Sciences, University of Guelph, Ontario, Canada
Department of Hematology, Maastricht University Medical Centre, the Netherlands
Department of Biochemistry, Cardiovascular Research Institute Maastricht, Maastricht University Medical Centre, the Netherlands
Department of Biochemistry, Cardiovascular Research Institute Maastricht, Maastricht University Medical Centre, the Netherlands
Vol. 103 No. 9 (2018): September, 2018 https://doi.org/10.3324/haematol.2017.185165